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Abstract
Background: The aim of the present study was to assess the reliability of a new strategy for monitoring the
serological response against Bovine Herpesvirus 1 (BoHV1), the causative agent of infectious bovine rhinotracheitis
(IBR). Bulk milk samples have already been identified as cost effective diagnostic matrices for monitoring purposes.
Nevertheless, most eradication programs are still based on individual standard assays. In a region of northwestern
Italy (Piedmont), the voluntary eradication program for IBR has become economically unsustainable. Being the
prevalence of infection still high, glycoprotein E-deleted marker vaccines are commonly used but gE blocking
ELISAs are less sensitive on bulk milk samples compared to blood serum.
Results: A recently developed indirect gE ELISA showed high versatility when applied to a wide range of matrices.
In this study, we applied a faster, cost effective system for the concentration of IgG from pooled milk samples. The
IgG enriched fractions were tested using a gE indirect ELISA for monitoring purposes in IBR-positive and IBR-marker-
vaccinated herds. Official diagnostic tests were used as gold standard. During a 3 years study, a total 250 herds
were involved, including more than 34,500 lactating cows. The proposed method showed a very good agreement
with official diagnostic protocols and very good diagnostic performances: only 37 positive animals were not detected
across the entire study.
Conclusions: The results highlighted the ability of the proposed method to support the surveillance of IBR in the
Piedmont region, reducing the costs without affecting the diagnostic performances.
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Background
Infectious bovine rhinotracheitis (IBR) is the most severe
disease caused by Bovine Herpesvirus 1 (BoHV1), an etio-
logical agent that is also responsible of other clinical forms
such as infectious pustular vulvovaginitis (IPV), abortions
and infectious pustular balanophostitis (IBV) [1, 2]. The
reactivation from the ganglia of latently infected cattle and
re-excretion of BoHV1 results in infection of susceptible
or even vaccinated hosts. Control measures for IBR are
justified by the substantial economic losses due to the
within-farm persistence and to the trade restrictions im-
posed by IBR-free countries [3].
Several conventional (whole-virus strains) and glyco-
protein E-deleted (gE) marker-vaccines are available to
contain the clinical forms and reduce the spread of
BoHV1. In parallel gE companion diagnostic tests were
developed. The gE blocking ELISAs detect antibodies
against the missing antigen, differentiating infected from
vaccinated animals (DIVA). The use of gE blocking
ELISA on milk is discouraged because the level of IgG is
about 1/15th of that found in serum and sensitivity is-
sues are not overcome even if un-diluted milk is tested
[4–6]. However, milk can easily be collected, pooled and
tested, thereby reducing the total costs of surveillance as
well as animal stress. According to EU Regulation (2004/
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558/EC), some prerequisites of BoHV1-bulk-milk testing
have to be met: pools must include no more than 50 in-
dividual milks (PM) and at least the 30% of cattle on
premises must be lactating; finally, the pool size is cali-
brated according to the limit of detection (LOD) of the
method. Whole-virus ELISAs were demonstrated fit for
monitoring purposes in IBR-free areas, where vaccin-
ation is forbidden. Nevertheless, if adopting a PM ap-
proach in marker-vaccinated (MV) farms only DIVA
tests could be employed, and blocking ELISAs could lack in
sensitivity and specificity [6, 7]. Concentration and purifica-
tion of IgG from milk by affinity chromatography (AC) par-
tially improved the LOD of blocking gE assays [8]. This
approach is however discouraged by the costs and the com-
plexity of the AC protocol. An alternative to AC could con-
sist in testing the IgG-enriched fraction, using cheaper
chemical reagents with no adverse effects on ELISA testing.
An indirect ELISA for the detection of IgG against the
gE of the BoHV1 was developed in previous studies [9, 10]
and showed good performance on serum, individual milk,
and purified/concentrated IgG from bulk milk (BM) sam-
ples. Since the LOD of the method in concentrated BM
was estimated to be equal to a prevalence of 2.5% infected
animals per pool, it could be reliable also in MV farms
monitoring.
In Piedmont, a voluntary eradication program is cur-
rently highly demanding in terms of human and material
costs and a further step towards a compulsory eradica-
tion program would be unsustainable. This surveillance
system is currently operating only in IBR-MV and
IBR-free herds, but by changing from blood serum to
PM based monitoring, substantial resources could be-
come available for a larger number of farms. Moreover,
animals belonging to IBR positive farms are tested only
for trade purposes. This aspect leaded to an inaccurate
definition on their IBR status at the begin of the study.
This lack of information was overcame during the study,
updating the official status of all the included farms.
In the present study, individual milk samples, collected
for functional feature analysis, were used for PM prepar-
ation and an integrated system of partners involved in a
cost effective IBR surveillance study was established. Sam-
ples were treated with an ammonium-sulphate based con-
centration protocol, replacing the more expensive AC
method. The concentrated PM samples, collected from
IBR-positive and IBR marker-vaccinated-farms were tested
in gE indirect ELISA. The aim of this study was to evalu-
ate the field diagnostic performance of the method in
comparison with the standard individual tests employed
in IBR surveillance.
Results
In the present study, approximately 65,000 individual
milks were used for the preparation of isovolumetric
pooled milk samples. The mean number of cows per
pool was 35 (each pool size ranged from 20 to 40 ani-
mals). Approximately 34,500 lactating cows were in-
volved in at least one pooled milk investigation, while
1500 animals (approximately 4%) were excluded for dry
period or for treatment with antibiotics. In accordance
with EU Decision 2004/558/EC, the aforementioned
1500 animals were individually tested by standard assays.
All the individual tests confirmed the previous status of
each animal.
Twenty-seven farms were excluded from data analysis
since the serological status of the lactating cows was not
up-to-date and the estimation of within-pool prevalence
could not be performed. Conversely, the IBR status of
the remaining 253 recruited farms was updated, permit-
ting the assessment of the diagnostic performance of the
method. The updating of the official status allows the
number of expected gE-negative farms to increase from
120 to 156, while the number of expected IBR-positive
herds was reduced to 97. Description of the farms IBR
status is reported in Table 1. In Fig. 1 each farm is
depicted according to the highest percentage of OD de-
tected in pooled samples across the entire study (y axis)
and the maximum number of expected positive animal
per pool (x axis).
The estimation of the diagnostic specificity (DSp) was
conducted on the results on all the pools including only
gE negative animals belonging to farms with both IBR
negative and positive farms status. Among all expected
negative pools (n = 1224), only 30 resulted in ELISA
positive outcome (diagnostic specificity at pool level dSp
= 97.55, 95%CI: 96.52–98.43%; at farm level dSp = 95.91,
95%CI: 96.15–100.00%). All of them belonged to four gE
negative farms. Further investigations revealed a recent
BoHV-1 wild type circulations, promptly detected by
pools testing (Fig. 2). The outbreaks were confirmed by
the gE blocking ELISA applied to serum samples of the
lactating cows. Considering the aforementioned out-
breaks, the final evaluation of the DSp at pool level was
calculated as 100% (95%CI: 99.69–100.00%). Considering
Table 1 Description of IBR status of the investigated farms
according with the presence or absence of antibodies against
the glycoprotein E (gE). Thirty involved farms (unknown status)
have been never investigated for BoHV1 (Bovine herpesvirus 1)
antibodies prior the present study
Farms May 20151 November 20162
gE-positive 152 97
gE-negative MV 98 156
Unknown status 30 0
Total 280 253
aMarker-vaccinated farms. The number of farms belonging to each group at
the beginning (1) and at the end (2) of the study is reported
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only gE negative farms, the dSp was 100% (95% CI:
96.15–100.00%).
Out of the 97 expected gE-positive farms, 81 con-
firmed their status in gE indirect ELISA performed on
IgG enriched fractions while 16 resulted negative across
the entire study, suggesting a raw estimation of the diag-
nostic sensitivity equal to 83.5% (95% CI: 74.6–90.3%). All
the 16 false negative farms were sampled 2 or 3 times and
the maximum number of expected positive animals was
recorded for each pool. The maximum number of
within-pool gE-positive animals ranged from 1 to 3 cows
(Fig. 1). A deeper investigation on those farms revealed
that 37 gE-positive animals were included in those false
negative pools. All the 37 animals have updated IBR sta-
tuses, confirming their gE positive status and were 3 to 12
years old (median = 5). Analyses conducted at farm level
indicated a very good agreement between the official sta-
tus and the ELISA results, showing a Cohen’s Kappa equal
to 0.8619 (95% CI: 0.7971–0.9268).
Discussion
Bulk milk or pooled milk testing is a valuable tool for
eradication and/or monitoring programs, where a large
number of cattle must be tested without inducing stress
on the animals and incurring in high costs [11, 12].
Nevertheless, the size of pooled milk samples, in accord-
ance with Decision 558/2004/CE, must be tailored to the
LOD of the serological method, ensuring the detection
of a single weak positive milk diluted in a modulated
pooled milk.
Fig. 1 Summary of ELISA Results. All the farms are showed: the
position in the plot is given by the maximum number of gE
(glycoprotein E) positive animals identified into the pools (x axis)
and on the maximum ELISA results recorded among all tested pools.
Black dots represent the results in agreement with Official IBR status;
grey dots represent the 4 recorded IBR re-infection in expected gE-
negative farms; white dots represents the 16 expected gE-positive
farms which always resulted negative to gE indirect ELISA. The
dotted lines indicate the threshold values of the gE indirect ELISA
Fig. 2 Distribution of IgG enriched fractions ELISA optical density (%OD) related to two/three sampling in the four farms (a, b, c, d) with new
BoHV1(Bovine Herpesvirus 1) outbreaks detected across the 18months of the present study. The dotted lines indicate the threshold values of the
gE (glycoprotein E) indirect ELISA
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The whole-virus ELISAs have been demonstrated the
most sensitive tool for the detection of antibodies
against BoHV1 in bulk milk samples [6]. However, in
farms where marker vaccination is adopted, whole virus
ELISAs fail to distinguish infected from vaccinated cows,
and only gE assays are suitable to monitor MV-herds. In
the last two decades, the only available tests for IBR in
MV-herds were gE blocking ELISAs, which were shown
to be less sensitive when applied to PM samples than on
individual blood samples (OIE Terrestrial Manual 2010,
[6]). Indeed, previous studies demonstrated the import-
ance of the within-pool prevalence and of the stage of
lactation (variable levels of IgG) in the sensitivity of gE
conventional assays [13]. Nevertheless, new strategies
can be adopted to increase sensitivity in BM or PM sero-
logical investigations [14] as well as in the surveillance
plan strategies [15]. In a recent study [10] we described
a new approach for IBR surveillance, based on the use of
a novel gE indirect ELISA applied to concentrated/puri-
fied BM samples. The concentration protocol consisted
in the use of an affinity matrix to bind the IgG that are
present in the whey and that can then be purified with a
spin-column system.
In the present study, we used the individual milk sam-
ples collected for routine functional feature evaluation
and identified by a barcode for the preparation of isovo-
lumetric PM samples (1 ml/head). Therefore, this ap-
proach bypasses the differences in daily milk production
that are often observed when using bulk tank milk.
Moreover, the planning of 2–3 sample collections across
18 months reduced the number of animals that were
never included in PM investigation to 1500 cows (dried
cows and bulls, namely 4.35% of the total), and these
had to be tested by individual standard assays.
The diagnostic specificity evaluation involved the 156
gE-negative farms, tested in two independent sample col-
lections and using the gE indirect ELISA applied to IgG
enriched fractions. Across the large number of PM sam-
ples tested, four cases of BoHV1-seroconversion were
promptly detected in the group of gE-negative herds. In-
deed, gE blocking ELISA applied to serum samples col-
lected from the four farms confirmed the presence of gE
specific antibodies. Even if marker vaccination was in
place in 3 out 4 of the new infected herds, the method
was demonstrated fit for the purpose of surveillance.
Regarding the 97 expected IBR-positive farms, 81 con-
firmed their actual IBR status in the outcomes of gE in-
direct ELISA, while 16 resulted negative. In the current
regional intervention program, recognized IBR-positive
farms are excluded from yearly monitoring and their of-
ficial status can stay unchanged for years, despite the
progressive elimination of infected heads. Therefore, the
number of expected positive farms changed from the be-
ginning of the study and a substantial number of herds
were reclassified as gE-negative. Only 16 farms scored
negative for the entire study even though recent individual
assays have identified 37 gE positive animals included in
the respective pooled samples. Those animals represent
around the 2% of all the positive animals (n = 1805) be-
longing to gE-positive farms enrolled in the present study.
The apparently false negative results can be partially
justified by reasons other than a possible lack in sensitiv-
ity of the proposed diagnostic approach. However this
condition has been recorded in very few occasions, at
least in the area of study and seems correlated to the use
of old conventional vaccines (whole virus vaccine, for-
bidden since 2003) rather than to true viral circulation.
Moreover we can not exclude that those animals showed
an antibodies titer in the milk samples lower than the
limit of detection of the proposed method. On the other
hand, new cases of infection were promptly detected
and tended to show very high reactivity in all the tested
pools regardless of vaccination status. Therefore, the
probability of a very small number of truly positive ani-
mals being present within the herd without the emer-
gence of an outbreak can be considered quite low.
Moreover, the absence of a true gold standard should be
taken into account as well as the diagnostic specificity
(DSp) value of the commercial gE blocking ELISA ap-
plied to serum samples of tested animals. Indeed, the
test DSp was measured at 92% [6] and this aspect could,
at least in part, justify our results, if we consider these
37 animals (less than one one-thousandth of the total
number of heads) as possible false-positive results in gE
blocking ELISAs.
Conclusions
Our findings provide compelling evidence in favor of the re-
liability a new strategy for IBR surveillance, which includes a
traceable and standardized system of PM preparation.
Investigation for IBR surveillance using PM samples
could represent a cost-effective solution for monitoring
herd-status. Moreover the pooled milk approach can in-
crease the number of serological investigations per year
from 1 to 2–3 (according to the herd-qualification),
allowing an earlier detection of new BoHV1 outbreaks.
We previously demonstrated that the concentration/
purification of IgG associated with a gE indirect ELISA
represent an effective strategy to overcome the sensitivity
issue in BM surveillance. When compared to previous
work, in this case we adopted a cheaper, easier and faster
protocol for the concentration of IgG from milk, and eval-
uated its fitness for monitoring purposes. A PM-based
surveillance program seems reliable if the pool size is de-
termined accounting for the LOD of the method. More-
over the humoral response against BoHV-1 wild-type
strains was found to be high in the target population, re-
gardless the presence of marker-vaccination. The present
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work was carried out using the preexisting infrastructure
for quality assurance programs, which was further im-
proved with a highly automated system of data collection
and analysis. The proposed method was proven fit for IBR
surveillance in gE-negative farms (DSp of 100%) but also
suggested its field applicability for eradication purposes.
Indeed, bulk milk samples could be collected from
gE-positive farms, processed, and tested until the relative
IgG enriched fractions became negative in gE ELISA. This
finding will suggest that the within-herd prevalence is low
and would justify the adoption of a pooled-milk-based ap-
proach. When all pooled milk of those farms test negative,
none or only few gE-positive heads are expected to be still
in lactation. Therefore, the final step in IBR eradication
would consist in the employment of the standard individ-
ual assays on blood serum to identify and slaughter the
last eventual gE-positive animals. Finally, another advan-
tage of the present study was the active participation of
different partners involved in sanitary procedures (ASL
and IZSPLV) and functional feature evaluations (ARAP),
ensuring the creation of an integrated system with future
applicability in different fields of health monitoring in
dairy herds.
Methods
Farms involved and planning of surveillance
Currently, the regional eradication program in Piedmont
includes different levels of IBR status qualifications,
based on the herd-immunity against BoHV1. IBR-free
farms do not adopt any vaccination program and the en-
tire herd must test negative to whole-virus assays.
IBR-marker-vaccinated farms include gE marker vacci-
nated and IBR-free animals, and new infections can be
detected using gE blocking ELISA through individual
testing. IBR-positive farms are defined by the presence
of antibodies against gE in at least one animal in diag-
nostic age (> 24months).
At the beginning of 2015, a group of 280 farms includ-
ing all IBR official statuses were voluntarily recruited for
the present study. All the farms included animals belong-
ing to dairy breeds, in most cases Friesian breed, with a
mean size of 80 lactating cows per farm. Milk was col-
lected during the ordinary lactating procedure: this aspect
allowed to select only the animals older than 24months,
and, consequently, to exclude the presence of maternal
antibodies and colostrum in the analyzed pools.
A total amount of 98 gE-negative IBR-marker-vaccinated
farms and 152 gE-positive farms (IBR-positive) were in-
cluded into two or three PM collection sessions. In
addition, 30 farms with unknown IBR status were enrolled
in the study and all animals older than 24months of age
were serologically tested using standard assays (SVANO-
VIR® IBR whole virus ELISA and IDEXX IBR gE Ab block-
ing ELISA). At the end of the project 254 farms out of 280
were serologically tested using official IBR-ELISAs, updat-
ing their IBR status and calculating the within-PM
prevalence.
Sample collection was performed across the full 18
months of the study and planned according to the guide-
lines of Decision 2004/558/EC for IBR eradication pro-
grams approved by the European Community: two
samples collections were performed in IBR-free and in
IBR-MV farms, while three PM preparations, four months
apart, were scheduled for the IBR-positive farms.
Pooled samples: Preparation, identification system and
data analysis
Individual milk samples are routinely collected once a
month by the Provincial Breeder Association (ARAP) of
Cuneo to monitor milk quality through functional fea-
ture evaluation. This existing source was used for the
preparation of PM samples. From each individual milk
sample, 1 ml was collected and used for the preparation
of pooled milk that could be processed with the down-
stream concentration protocol. Each PM sample was
identified using a barcode that uniquely identified it and
allowed retrieval of the individual ear tags of included
animals. Data was stored into a SQL relational database
and an ad hoc developed web application was used to
interact with the Regional Veterinary database, where
diagnostic information is stored by the Official Veterin-
ary Service. This interaction allows retrieval of IBR sta-
tus (i.e negative, vaccinated or positive) and diagnostic
history of each animal included in the pool. This web
application also guides the operator in the identification
of the optimal pool size (20–40 animals) to optimize
LOD based on farm composition.
Ammonium-sulphate based IgG concentration
Ten ml from each PM were treated with 100 μl of a ren-
net based solution to precipitate the caseins during an
incubation time of 20 min at 37 °C. The obtained curd
was broken by manual agitation and incubated on ice
for 10 min. The samples were centrifuged at 3600 g for
10 min at 4 °C to obtain three different fractions: a fat
layer on top, the whey in the middle and a casein pellet
at the bottom of the tube. The whey was transferred to a
new 14ml tube, mixed with an equal volume of a satu-
rated solution of ammonium sulphate (4.1M at 25 °C)
and incubated on a platform shaker for 1 h. After add-
itional centrifugation (3600 g for 10 min at 18 °C), an
enriched IgG fraction was visible at the bottom of the
tube [16–18]. The supernatant was discarded and the
pellet was briefly drained upside down on a paper towel
before being resuspended in 400 μl of PBS 1.25% casein.
The described protocol allowed a concentration of the
milk IgG of about 15X (data not showed). This result is
in agreement with previous published data [10]. Even if
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a different purification method was used, the ammonium
sulphate based precipitation method showed a very com-
parable efficiency. The enriched fractions of IgG were
used immediately in the downstream ELISA protocol or
alternatively stored at − 20 °C.
Serological assays
The gE indirect ELISA (ERADIKIT ™ Bulk Milk surveil-
lance Kit, In3diagnostic, Italy), described in two previous
papers [10], originally developed for the detection of anti-
bodies in serum or concentrated/purified BM samples, was
adapted for application on IgG enriched fractions obtained
from PM samples collected in IBR-MV and in IBR-positive
farms. The ELISA protocol was slightly modified based on
the different diagnostic matrix to be investigated. Briefly,
the enriched fractions were placed into two adjacent wells
(200 μl/well), the former coated with the recombinant
BoHV1 gE, while the latter with a negative antigen. The
starting incubation was performed at room temperature
(RT) for 120′ minutes. The plate was washed four times
and a peroxidase-labeled secondary antibody diluted at 10
ng/ml in PBS 1.25% casein was added to each well. After
45min of incubation at room temperature, four new wash-
ing cycles were performed before the addition of the sub-
strate solution (3,3′,5,5′-tetramethylbenzidine, TMB). The
reaction was stopped after 15min using 100 μl/well of stop
solution and read in a microplate spectrophotometer at
450 nm. The reactivity of each sample was calculated as the
ratio, expressed as percentage, between the net OD value of
the sample (gE-OD value – negative antigen OD value) and
the net OD value of the positive control (gE-OD value –
negative antigen OD value).
Samples with a percentage of reactivity equal to or
greater than 40% were classified as positive, those with re-
activity between 30 and 40% as doubtful, and those with a
reactivity lower than 30% were considered negative.
Data analyses
To evaluate the diagnostic performances of the proposed
protocol, the ELISA results were compared to the num-
ber of positive animals within each milk pool. The goal
was to evaluate the ability of the diagnostic protocol to
show positive results if at least one gE positive animal
was included in the pool. Results of official serological
diagnostic procedures were used as gold standard. Diag-
nostic sensitivity and specificity were evaluated at pool
level, as well as at farm level (i.e. all pools collected from
a farm during the 18 months surveillance period, fitting
the surveillance purpose of the method). The concord-
ance between the results obtained during the study and
the official serological investigations was calculated at
farm level by Kappa Cohen coefficient. In more details, a
farm from which at least one tested milk pool included
at least one gE positive animal was considered as
expected positive farm. Confidence interval of diagnostic
sensitivity and specificity was calculated using Exact Bi-
nomial test (R Statistical software ver. 3.2.0).
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